Croma-Pharma
Slavica Hell serves as a Project Manager in R&D at Croma Pharma since March 2017, leading the development of medical devices for the EU and US markets, overseeing manufacturing process development, validation, change control, risk management, and process optimization. Previously, Slavica worked as a Trainee in R&D, participating in development projects and performing material qualification and data assessment for validation batches. Academic experience includes a research assistant role at BOKU University, focusing on the modification and utilization of cellulosic fibers, and a university assistant position at the University of Vienna. Education includes a Dr.nat.techn. in Chemistry from BOKU University and a Master’s degree in Physical Chemistry from the University of Belgrade.
This person is not in any offices
Croma-Pharma
4 followers
Croma is a global player in the minimally invasive aesthetics market and a leading European manufacturer of premium quality hyaluronic acid syringes. The company offers a comprehensive and innovative aesthetics portfolio including botulinum toxin, fillers, lifting threads and biostimulators complemented by its own skincare brand. Founded in 1976 by a pharmacist couple, Croma-Pharma GmbH is a family company headquartered in Austria where it also operates its manufacturing plant. With 550 employees, 13 subsidiaries in Europe and Brazil, two joint ventures and 60 exclusive export partners, it distributes its products in 80 markets globally, including the US, Canada, China, Australia and New Zealand. It also operates as a contract manufacturer in orthopaedics and ophthalmology. For more information please visit cromapharma.com.